Recent news on

APA: SSRIs More Likely in Suicides than in Other Young Deaths  -  25 May 2007
Psychiatric Times,..."Even though both amitriptyline and doxepin are highly serotonergic tricyclic antidepressants, no tricyclic antidepressants appeared in toxicology findings

APA: SSRIs More Likely in Suicides than in Other Young Deaths  -  25 May 2007
MedPage Today,..."Even though both amitriptyline and doxepin are highly serotonergic tricyclic antidepressants, no tricyclic antidepressants appeared in toxicology findings

Somaxon: Silenor data offers promise, but generic challenge awaits  -  May 24, 2007
Pharmaceutical Business Review...'Content Somaxon's Silenor is a low-dose oral tablet formulation of the non-addictive dibenzoxepin tricyclic antidepressant doxepin, which has been marketed

Somaxon says may delay seeking approval for sleep drug  -  May 9, 2007
Reuters.uk,Silenor consists of a low-dose version of an old antidepressant called doxepin and Somaxon says it does not expect regulators to label it a controlled

Somaxon Pharmaceuticals Provides Update on Silenor Development Program  -  May 10, 2007
PipelineReview.com (press release),Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR(TM) (doxepin HCl) for the treatment of insomnia.

Antidepressants linked to suicide risk in young adults  -  May 5, 2007
Food Consumer,Remeron (mirtazapine), Sarafem (fluoxetine HCl), Seroquel (quetiapine), Sinequan (doxepin), Surmontil (trimipramine), Symbyax (olanzapine/fluoxetine),

Will there soon be a cure for everything?  -  May 1, 2007
Belfast Telegraph,First in the queue is Silenor (chemical name doxepin) made by California-based Somaxon Pharmaceuticals, which is expected to be licensed in the US within

Inactivated heterologous on whom was later determined.  -  Apr 19, 2007
LIVE-Wintersport.com,Province in from exposure are usually Doxepin percent say Piroxicam uses. Motivational enhancement illness among novel agent was soon Enbrel tryptophan.

Somaxon Pharmaceuticals to Present at Upcoming Fortis, Morgan ...  -  Apr 19, 2007
PharmaLive.com (press release),Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR(TM) (doxepin HCl) for the treatment of insomnia.

Chronic hives: What causes them?  -  Apr 10, 2007
MayoClinic.comSome people with chronic hives also benefit from low doses of doxepin, a tricyclic antidepressant with antihistamine properties.

Finally, An Unbiased Drug Source Has Arrived  -  Apr 5, 2007
Evening Bulletin,Tricyclic Antidepressant : Amtripyline (Elavil, and others); doxepin (Sinequan, and others). * First-Generation Antihistamines: Chlorpheniramene

Pharmaceutical manufacturing: People on the move  -  Apr 4, 2007
In-PharmaTechnologist.com,...are relying on L'Italien's expertise to help successfully prepare for its submission of a New Drug Application for its insomnia drug, Silenor (doxepin).

Pharmacy break-in solved; drugs recovered in 16 hours  -  Apr 3, 2007
Oscoda Press,Stolen were addictive Doxcycline, Hydrocodone, Vicodin, Carisoprodol, Doxepin and Singulair, according to OTPD Chief Robert LaVack.

Somaxon Pharmaceuticals to Update Preclinical Program for SILENOR ...  -  Feb 13, 2007
PharmaLive.com (press release),Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR(TM) (doxepin HCl) for the treatment of insomnia.

Somaxon Provides Update on SILENOR(TM) Preclinical Program  -  Feb 14, 2007
PipelineReview.com (press release),SILENOR(TM) is a low-dose (1 mg, 3 mg, 6 mg) oral tablet formulation of doxepin HCl that is patent protected for its use in insomnia.

Biotech Day In Review: Another Setback for Acomplia from Sanofi ...  -  Feb 14, 2007
Seeking Alpha,The compound is a low-dose version of a 35-year-old depressions/anxiety drug, doxepin HCl, that is patented for insomnia. Somaxon was up 35 cents at $13.40.

Market Report -- In Play (SOMX)  -  Feb 13, 2007
MSN MoneySomaxon Pharma: FDA agrees with the co's assessment that doxepin does not appear to have genotoxic potential Co is providing an update on its preclinical

Somaxon Pharmaceuticals to Present at the JPMorgan Healthcare ...  -  Jan 3, 2007
WebWire (press release),Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR™ (doxepin HCl) for the treatment of insomnia.

BUY CARISOPRODOL , carisoprodol , buy soma , cheap soma online  -  Dec 25, 2006
Indymedia Colombia,Antihistamines such as doxepin (Sinequan), imipramine (Tofranil), nortriptyline (Pamelor), fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft),

Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical ...  -  Dec 18, 2006
PharmaLive.com (press release),Somaxon has completed four successful Phase 3 clinical trials for its lead product candidate, SILENOR(TM) (doxepin HCl) for the treatment of insomnia.

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
WebWire (press release),Somaxon’s lead product candidate, SILENOR™ (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

BUY CARISOPRODOL , carisoprodol , buy soma , cheap soma online  -  Dec 25, 2006
Indymedia Colombia,Antihistamines such as doxepin (Sinequan), imipramine (Tofranil), nortriptyline (Pamelor), fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft),

Wal-Mart $4 Generics Program Launched In Wyoming  -  Nov 27, 2006
Yahoo! News (press release)75MG TAB Citalopram 20MG TAB Citalopram 40MG TAB Doxepin HCL 100MG CAP Doxepin HCL 10MG CAP Doxepin HCL 25MG CAP Doxepin HCL 50MG CAP Doxepin HCL 75MG

Somaxon’s SILENOR™ Demonstrates Positive Results in Long-Term ...  -  Dec 19, 2006
PipelineReview.com (press release),Inc. (NASDAQ:SOMX) today announced positive results from the company’s Phase 3 clinical trial evaluating SILENOR™ (doxepin HCl) in elderly patients with

Somaxon sees late-stage Silenor results  -  Dec 18, 2006
BusinessWeekThe drug has already been on the market in higher doses for decades as doxepin, used to treat anxiety and depression. The FDA has requested preclinical

Somaxon Stock Perks Up With News  -  Dec 18, 2006
San Diego Business Journal,The 12-week, double blind, placebo-controlled study involving 240 elderly patients with chronic insomnia showed the drug, doxepin, worked well.

Somaxon’s Insomnia Drug Shown to Be Effective in Phase III Trial  -  Dec 18, 2006
Genetic Engineering News (press release),Somaxon Pharmaceuticals reported positive results from a Phase III trial evaluating Silenor™ (doxepin HCl) in elderly patients with chronic primary insomnia

Somaxon's Silenor Demonstrates Positive Results in Long-Term Phase ...  -  Dec 18, 2006
PharmaLive.com (press release),Inc. (NASDAQ:SOMX) today announced positive results from the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl) in elderly patients

Somaxon's SILENOR(TM) Demonstrates Positive Results in Long-Term ...  -  Dec 18, 2006
Genetic Engineering News (press release),Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) today announced positive results from the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl)

Somaxon Reports Results From a Clinical Trial of Oral Nalmefene in ...  -  Dec 13, 2006
Big OC News (press release)Somaxon s lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Drug treatment for gambling is ineffective, Somaxon says  -  Dec 6, 2006
San Diego Union Tribune,Silenor is no exception: It is a low-dose form of an already approved drug, doxepin, which is used to treat depression. If approved as an insomnia treatment

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
PharmaLive.com (press release),Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
Business Wire (press release),Somaxon’s lead product candidate, SILENOR ™ (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Somaxon Reports Results From a Clinical Trial of Oral Nalmefene in  -  Dec 5, 2006
WebWire (press release),Somaxon’s lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)The use of trazodone and other antidepressants (including tricyclic antidepressants such as amitriptyline and doxepin and newer agents such as mirtazapine)

Somaxon Pharmaceuticals Reports 2006 Third Quarter Financial ...  09 Nov 2006
...neurology. Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. ... -Yahoo! News (press release) Wal-Mart Brings $4 Generic Program To Ohio  Oct 26, 2006
100MG TAB Amitriptylin 10MG TAB Amitriptylin 25MG TAB Amitriptylin 50MG TAB Amitriptylin 75MG TAB Citalopram 20MG TAB Citalopram 40MG TAB Doxepin HCL 100MG CAP ... -PR Newswire (press release), Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results ...  Oct 24, 2006
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced positive results from the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl) in ... -Medical News Today (press release), Wal-Mart and Sam's Clubs Bring $4 Generic Prescription Program to ...  Oct 19, 2006
100MG TAB Amitriptyline 10MG TAB Amitriptyline 25MG TAB Amitriptyline 50MG TAB Amitriptyline 75MG TAB Citalopram 20MG TAB Citalopram 40MG TAB Doxepin HCL 100MG ... -PR Newswire (press release), Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical ...  Oct 24, 2006
...today said that, tomorrow morning, Monday, October 23, the company plans to issue results from its Phase 3 clinical trial of SILENOR(TM) (doxepin HCl) for the ... -Drug Newswire (press release), Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results ...  Oct 23, 2006
SILENOR(TM) is a low-dose (1 mg, 3 mg, 6 mg) oral tablet formulation of doxepin HCl that is patent protected for its use in insomnia. ... -Earthtimes.org What's on Wal-Mart's list?  Oct 27, 2006
...sulf/TMP. Antidepressant: Amitriptyline; citalopram; doxepin Hcl; fluoxetine; nortriptyline; paroxetine; trazodone. Antipsychotic ... -Cincinnati Enquirer, Somaxon Pharma Reveals Positive Results From Phase 3 Trial Of ...  Oct 23, 2006
...feeling refreshed. SILENOR is a low-dose oral tablet formulation of doxepin HCl that is patent protected for its use in insomnia. -Trading Markets, Market Report -- In Play (SOMX)  Oct 23, 2006
...results in a Phase 3 Transient Insomnia clinical trial Co announces positive results from the co's Phase 3 clinical trial evaluating SILENOR (doxepin HCl) in ... -MSN Money Somaxon Pharmaceuticals Provides Update On Preclinical And ...  Sep 12, 2006
SOMX) today announced that it has completed the genotoxicity studies requested by the US Food and Drug Administration (FDA) for SILENOR(TM) (doxepin HCl), the ... -Medical News Today

Somaxon Pharmaceuticals to Present at the Merrill Lynch Global ...  Sep 19, 2006
...neurology. Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. ... -Yahoo! News

Somaxon Pharma Says Studies For Insomnia Drug Candidate Silenor ...  Sep 11, 2006
...the assays. Silenor is a low-dose oral tablet formulation of doxepin HCl. It is patent protected for its use in insomnia. The company ... -Trading Markets

Lubricated condoms may not protect against HIV  Sep 12, 2006
...of the puzzle. Conventional doctors often use tranquilizers like alprazalam or antidepressants like doxepin or Zoloft. But Zoloft ... -Newsday

Prevention Strategies Reviewed for Women With Migraines  Sep 6, 2006
...propranolol, timolol, atenolol, metoprolol, nadolol); tricyclic antidepressants (amitriptyline, nortriptyline, protriptyline, doxepin); calcium channel ... -Medscape (subscription)

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
WebWire (press release),Somaxon’s lead product candidate, SILENOR™ (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results ...  -  Nov 20, 2006
PR Newswire (press release),SILENOR(TM) is a low-dose (1 mg, 3 mg, 6 mg) oral tablet formulation of doxepin HCl that is patent protected for its use in insomnia.

Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical ...  -  Nov 20, 2006
PharmaLive.com (press release),Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Nalmefene HCl is in a Phase 2/3

Wal-Mart's $4 Generics Program Launched In Final 11 States  -  Nov 27, 2006
PR Newswire (press release),75MG TAB Citalopram 20MG TAB Citalopram 40MG TAB Doxepin HCL 100MG CAP Doxepin HCL 10MG CAP Doxepin HCL 25MG CAP Doxepin HCL 50MG CAP Doxepin HCL 75MG

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
PharmaLive.com (press release),Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
Business Wire (press release),Somaxon’s lead product candidate, SILENOR ™ (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Somaxon Reports Results From a Clinical Trial of Oral Nalmefene in  -  Dec 5, 2006
WebWire (press release),Somaxon’s lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. Somaxon has completed a successful

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)The use of trazodone and other antidepressants (including tricyclic antidepressants such as amitriptyline and doxepin and newer agents such as mirtazapine)

Somaxon insomnia drug shows positive results  -  Nov 21, 2006
ReutersSilenor is a low dose oral tablet formulation of doxepin HCl, a drug that has been prescribed for years in higher doses as a treatment for depression and

Somaxon Pharmaceuticals’ SILENOR™ Demonstrates Positive Results in ...  -  Nov 21, 2006
PipelineReview.com (press release),...results from the company’s Phase 3 clinical trial evaluating SILENOR™ (doxepin HCl) in elderly patients with primary sleep maintenance insomnia.

Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results ...  -  Nov 21, 2006
Medical News Today (press release),Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced positive results from the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl)

Somaxon Pharmaceuticals' Silenor Demonstrates Positive Results in ...  -  Nov 20, 2006
PharmaLive.com (press release),...results from the company's Phase 3 clinical trial evaluating SILENOR(TM) (doxepin HCl) in elderly patients with primary sleep maintenance insomnia.

People's Pharmacy: Look for warning signs of heatstroke ...  Aug 19, 2006
...car. Older drugs for depression - amitriptyline, desipramine, doxepin and imipramine, for example - can interfere with sweating. ... -Bryan College Station Eagle

Somaxon Pharmaceuticals Reports 2006 Second Quarter Financial ...  Aug 9, 2006
Operating expenses grew as expected and were primarily due to the company's ongoing Phase 3 clinical trials for SILENOR(TM) (doxepin hydrochloride), Phase 2/3 ... -Yahoo! News

Somaxon Pharmaceuticals Reports 2006 Second Quarter Financial ...  Aug 9, 2006
Operating expenses grew as expected and were primarily due to the company’s ongoing Phase 3 clinical trials for SILENOR™ (doxepin hydrochloride), Phase 2/3 ... -WebWire

Somaxon Pharmaceuticals Reports Positive Results From a Pilot ...  Jul 26, 2006
...neurology. Somaxon's lead product candidate, SILENOR(TM) (doxepin HCl), is in Phase 3 clinical trials for the treatment of insomnia. ... -Yahoo! News

Somaxon Pharmaceuticals Provides Update On SILENOR(TM) Development ...  Jul 20, 2006
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today is providing information on its development program for SILENOR(TM) (doxepin HCl), its lead drug candidate ... -Medical News Today

Somaxon Meets FDA Request for Study  Jul 19, 2006
FDA had requested preclinical information on Silenor, for which Somaxon originally planned to ask for a waiver because its active ingredient, doxepin, has been ... -Houston Chronicle

Somaxon Pharmaceuticals to Report 2006 Second Quarter Financial ...  Jul 18, 2006
Somaxon's lead product candidate, SILENOR(TM) (doxepin hydrochloride), is in Phase 3 clinical trials for the treatment of insomnia. ... -Drug Newswire

Former Mayes County jailer accused of drugging co-worker  Jul 12, 2006
...drink. Tawnya Brewer of Salina is accused of putting the anti-depressant Doxepin in the soft drink of Cevin (KEVIN) Smallwood. Investigators ... -KTEN

Somaxon Pharmaceuticals Announces Presentation Of Phase 2 SILENOR ...  Jun 21, 2006
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that data from its Phase 2 clinical trial evaluating three doses of SILENOR(TM) (doxepin HCL) in ... -Medical News Today

Going off depression medications risks relapse  Jul 9, 2006
Dear Mayo Clinic: I’ve been taking doxepin for depression for 15 years. Is it safe to take antidepressant medications for such a long time? ... -Fort Wayne Journal Gazette

Somaxon Pharmaceuticals Announces Presentation of Phase 2 SILENOR ...  Jun 20, 2006
...(NASDAQ: SOMX) today announced that data from its Phase 2 clinical trial evaluating three doses of SILENOR(TM) (doxepin HCL) in elderly adults with insomnia ... -PR Newswire

Pharmacy: High temps make some sensitive to heat exhaustion  Jul 16, 2006
...on a car. Older drugs for depression, like amitriptyline, desipramine, doxepin or imipramine, can interfere with sweating. So can ... -Houston Chronicle

Somaxon Drops After Analyst Lowers Target  Jul 5, 2006
However, the company noted the FDA recently requested preclinical studies on Silenor, which uses the generically named doxepin as an active ingredient. ... -Houston Chronicle

Henrico jail inmate dies  Jul 11, 2006
...said. Morris was taking anti-depressant medication called Doxepin that was administered to him by the jail's medical staff. "Apparently ... -Richmond Times Dispatch

Somaxon shares off 11 percent  Jul 6, 2006
The San Diego specialty pharmaceutical company is developing the sleep-aid, dubbed Silenor, which uses the generic drug doxepin as the active ingredient. ... -San Diego Union Tribune

What Happened to Lithium? Antidepressant Augmentation in Clinical ...  Jun 30, 2006
The antidepressants considered in this study included amitriptyline, desipramine, doxepin, imipramine, clomipramine, nortriptyline, phenelzine, tranylcypromine ... -Am J Psychiatry (subscription)



Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of ...  16 May 2006
Somaxon's lead product candidate, SILENOR(TM) (doxepin hydrochloride), is in Phase 3 clinical trials for the treatment of insomnia. ... - PR Newswire

Somaxon Pharmaceuticals Reports 2006 First Quarter Financial ...  May 10, 2006
...significant progress in its drug development programs, including completion of the first Phase 3 clinical trial for SILENOR(TM) (doxepin hydrochloride), its ... - Yahoo! News

Expert: Police shooting victim suicidal  Apr 27, 2006
Toxicology tests showed that Sonnier had both cocaine and the anti-depressant Doxepin in his system on the day he died. In a footnote ... - Uniontown Herald Standard

Pa. Supreme Court May Consider Whether Experts Can Extrapolate  Apr 26, 2006
At trial, the defendant tried to stop the plaintiff's expert from extrapolating conclusions about the adverse effects of the drug, Doxepin, based on ... - New York Law Journal





Good results for sleep aid buoy shares of Somaxon  11 Apr 2006
...to produce addiction. Silenor is a low-dose form of doxepin, a generic drug that has been used for decades to treat depression. - San Diego Union Tribune

Somaxon Pharmaceuticals Reports 2005 Full-Year Financial Results  Mar 21, 2006
..."During the year we reported positive results from two Phase II clinical trials with our lead product candidate SILENOR(TM) (doxepin hydrochloride) and ... - MSN Money

Somaxon Pharmaceuticals to Report 2005 Financial Results and Host ...  Mar 14, 2006
Somaxon's lead product candidate, SILENOR(TM) (doxepin hydrochloride), is in Phase III clinical trials for the treatment of insomnia. ... - PR Newswire

The Global Market for Sleep-Wake Disorders Currently Estimated at ...  Mar 9, 2006
...and Rozerem, with up to four further drugs expected to be approved and launched over the next 18 months including Indiplon, Gaboxadol, Doxepin, and Posidorm. ... - Genetic Engineering News

Health Tip: Drugs to Avoid While Breast-Feeding  Feb 16, 2006
Antidepressant drugs: Amitriptyline, Amoxapine, Bupropion, Clomipramine, Desipramine, Dothiepin, Doxepin, Fluoxetine, Fluvoxamine, Imipramine, Nortriptyline ... - Forbes

Somaxon Pharmaceuticals, Inc. to Present at the 18th Annual Roth ...  Feb 15, 2006
Somaxon's lead product, SILENOR(TM) (doxepin hydrochloride) 1mg, 3mg, 6mg, is in Phase III clinical trials for the treatment of insomnia. - PharmaLive.com,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional